Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TRACENTREAT

Financiado

Cerrado

Molecular technology for nuclear imaging and radionuclide therapy

Cancer is undoubtedly becoming the second largest cause of death in the EU. Future predictions are very somber expecting worldwide 17.5 million deaths and 27 million new cases annually by 2050. New innovative research and properly... ver más

30/09/2016

TU Delft

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

TECHNISCHE UNIVERSITEIT DELFT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 7 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-09-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

7 Participantes

TU Delft

0.00€ | Lider

MILABS BV

N.D. | Participante

UGent

N.D. | Participante

Proyectos interesantes

FPA2016-78987-P

Medical Technol...

Applied Physics

182K€ Cerrado

MEDICIS-PROMED

Medical Technol...

Applied Physics

3M€ Cerrado

PTA2012-7791-I

Medical Technol...

Applied Physics

36K€ Cerrado

EQC2021-007636-P

Medical Technol...

Applied Physics

974K€ Cerrado

RADIOBIO

Medical Technol...

Applied Physics

2M€ Cerrado

Radiopharm Metal Iso

Medical Technol...

Chemical Engine...

209K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

TECHNISCHE UNIVERSITEIT DELFT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer is undoubtedly becoming the second largest cause of death in the EU. Future predictions are very somber expecting worldwide 17.5 million deaths and 27 million new cases annually by 2050. New innovative research and properly educated generation of young scientists in fields related to cancer prevention, diagnostics, treatment and management is the only way to ensure progress in solving this issue. The aim of this proposal is to provide starting researchers with the skills necessary to become highly-qualified, health-associated professionals and contribute in the fight against cancer using nuclear imaging techniques and therapeutic methods. In this project the researchers will be given a broad insight in molecular imaging and radionuclide therapy with specialization in two of the following fields: Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging, soft matter, and in nuclear-, organic-, polymer- and radiopharmaceutical chemistry. The training will be provided based on a research project concerning the development of molecular and supramolecular carriers for nuclear imaging and radionuclide therapy and their pre-clinical evaluation. The fellows will be trained by a carefully selected consortium consisting of specialists and research leaders in the required fields, including the private sector. Secondments, workshops and regular meetings are included in the training to ensure the achievement of the set goal. Besides the research training, the fellows will be given the opportunity to acquire soft skills such as product development and marketing. The proposed training program will result in the development of highly-educated health-associated professionals with career prospects both in academia and industry. Additionally, through this ITN framework a long lasting collaboration will be established between the partners, ensuring both excellent research prospective and training possibilities for future fellows.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores